0.00
-0.0006(-40.00%)
Currency In USD
Address
360 Madison Avenue
New York City, DE 10017
United States of America
Phone
212 949 4319
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
39
First IPO Date
April 10, 2018
| Name | Title | Pay | Year Born |
| Dr. Lishan Aklog M.D. | Chairman & Chief Executive Officer | 953,200 | 1966 |
| Dr. Brian J. deGuzman M.D. | Executive Vice President, Chief Technology & Compliance Officer | 427,600 | 1965 |
| Mr. Shaun M. O'Neill M.B.A. | Executive Vice President & Chief Operating Officer | 498,000 | 1983 |
| Mr. Dennis M. McGrath CPA | President & Chief Financial Officer | 673,500 | 1957 |
| Mr. Michael Adam Gordon | Executive Vice President, General Counsel & Secretary | 710,500 | 1975 |
| Dr. Suman M. Verma M.D., Ph.D. | Senior Vice President of Molecular Genetics & Chief Scientific Officer | 0 | N/A |
| Dr. Victoria T. Lee M.D. | Senior Vice President & Chief Medical Officer | 0 | N/A |
| Dr. Deepika A. Lakhani Ph.D. | Senior Vice President, Chief Regulatory & Quality Officer | 0 | N/A |
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.